| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9254198 | Journal of Hepatology | 2005 | 5 Pages |
Abstract
A 6-month course of PEG-IFN α-2b is effective in inducing resolution of AHC in 94% of patients. Our results provide a rationale for delaying treatment for 12 weeks, targeting only patients who fail to clear the virus spontaneously and truly requiring therapy without loss of efficacy.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Teresa Santantonio, Massimo Fasano, Emanuele Sinisi, Angela Guastadisegni, Caterina Casalino, Michele Mazzola, Ruggiero Francavilla, Giuseppe Pastore,